Sort
25,944 grants matching “neurodegeneration”
Saracatinib and 1400W Counteract Nerve Agents-Induced Long-Term Neurotoxicity
$756,847Thimmasettappa Thippeswamy · Iowa State University · U01 · FY2024 · NS
Changes across the lifespan in the use of heuristics to guide decision-making
$756,837Michele A Basso · University Of Washington · R01 · FY2022 · AG
Sleep Disordered Breathing in normal elderly and risk for Alzheimers Disease
$756,611Ricardo S Osorio · New York University School Of Medicine · R01 · FY2015 · HL
Integrative genomic, transcriptomic, and proteomic analyses to investigate sex-specific differences in Alzheimer's Disease
$756,545Thomas Spurgeon Wingo · University Of California At Davis · R01 · FY2025 · AG
KBASE2: Korean Brain Aging Study, Longitudinal Endophenotypes and Systems Biology
$756,465Andrew J Saykin · Indiana University Indianapolis · U01 · FY2025 · AG
Brain and blood N-glycome profiling in Alzheimer's disease
$756,427Jinying Zhao · University Of South Florida · R01 · FY2025 · AG
Deciphering the Glycan Code in Human Alzheimer's Disease Brain
$756,289Ramon C. Sun · University Of Florida · R01 · FY2024 · AG
TREM2-mediated microglial dynamic function in Alzheimer disease
$756,237Guojun Bu · Mayo Clinic Jacksonville · R01 · FY2020 · AG
White matter degeneration: biomarkers in preclinical Alzheimer's Disease
$756,180Barbara Brigitta Bendlin · University Of Wisconsin-Madison · R01 · FY2023 · AG
Retinal circuit disassembly in primate glaucoma
$756,073Yvonne Ou · University Of California, San Francisco · R01 · FY2023 · EY
Cerebrovascular Remodeling and Neurodegenerative Changes in Alzheimer's Disease
$756,063Yanhang Katherine Zhang · Boston University (Charles River Campus) · R01 · FY2025 · AG
The impact of AD-associated genetic variants in 3D human mixed neural-glial models of AD
$756,000Rudolph Emile Tanzi · Massachusetts General Hospital · R01 · FY2021 · AG
The impact of AD-associated genetic variants in 3D human mixed neural-glial models of AD
$756,000Rudolph Emile Tanzi · Massachusetts General Hospital · R01 · FY2020 · AG
The impact of AD-associated genetic variants in 3D human mixed neural-glial models of AD
$756,000Rudolph Emile Tanzi · Massachusetts General Hospital · R01 · FY2022 · AG
The impact of AD-associated genetic variants in 3D human mixed neural-glial models of AD
$756,000Rudolph Emile Tanzi · Massachusetts General Hospital · R01 · FY2023 · AG
Novel pediatric anticonvulsants for nerve agents
$755,985Doodipala Samba Reddy · Texas A&M University Health Science Ctr · U01 · FY2020 · NS
Multiplexed Quantification of the Protein Poly-ADP-Ribosylation Landscape in C9ORF72-ALS/FTD
$755,606Yonghao Yu · Columbia University Health Sciences · R01 · FY2024 · NS
KLOTHO and Resilience to Synaptic Dysfunction in Preclinical AD
$755,566Ira Frahmand · University Of Wisconsin-Madison · R01 · FY2025 · AG
Cellular Viscosity as a Marker for Alzheimerâs Disease Pathology: A Combined Multiparametric MR Spectroscopy and PET Study
$755,524Ivan Ivanov Kirov · New York University School Of Medicine · R01 · FY2023 · AG
SV2A PET imaging in Alzheimer's Disease
$755,504Barbara Brigitta Bendlin · University Of Wisconsin-Madison · R01 · FY2019 · AG
Multi-cohort study of factors that influence Alzheimer's disease biomarker and dementia timing
$755,322Tobey James Betthauser · University Of Wisconsin-Madison · R01 · FY2025 · AG
Mapping Synaptic Density in Prodromal and Manifest Lewy Body Dementia
$755,300Catherine L. Gallagher · University Of Wisconsin-Madison · R01 · FY2024 · AG
Treating primary progressive aphasia and elucidating neurodegeneration in the language network using transcranial direct current stimulation
$755,036Roy H Hamilton · University Of Pennsylvania · R01 · FY2021 · AG
Intersection of HSV-1 and microglial genetics in AD
$754,873Elizabeth M Bradshaw · Columbia University Health Sciences · R01 · FY2022 · AG
Circulating and Brain Lipidomics, Cognition and Dementia
$754,765Dan E Arking · Johns Hopkins University · R01 · FY2025 · AG